Category: Antibody Therapies

  • AbCellera Enters into a License Agreement with Everest to Discover Antibody Therapies

    Shots: Everest to get the rights to develop & commercialize Abs resulting from the collaboration. AbCellera to receive research payments and is eligible to receive clinical and commercial milestones along with royalties on net sales of products The collaboration will accelerate Everest’s portfolio to discover novel medicines for up to 10 targets across multiple indications […]